Avalyn Pharma and CRISPR Therapeutics agreed to expand the total leased area to approximately 13,700 square feet. This amendment enhances operations at the Boston facility.
Avalyn Pharma and CRISPR Therapeutics agreed to expand the total leased area to approximately 13,700 square feet. This amendment enhances operations at the Boston facility.